skip to Main Content

EQ-5D-5L | Valuation | New UK EQ-5D-5L Valuation Study | ARCHIVE

Quality Control team appointed

August 16, 2022 In line with the study governance document, the Steering Group has appointed the following four scientists as members of the Quality Control (QC) team: Michal Jakubszyk (Division of Decision Analysis and Support, Institute of Econometrics, SGH Warsaw School of Economics , Poland) John Mullahy (Univ. of Wisconsin-Madison,…

Study team co-investigators updated

August 16, 2022 The research team for the UK EQ-5D-5L valuation study has been updated. The lead investigator is Donna Rowen (School of Health and Related Research, University of Sheffield) and co-investigators are: Nathan Bray (Centre for Health Economics and Medicines Evaluation, Bangor University) Jill Carlton (School of Health and…

Steering Group updated

August 16, 2022 There have been a few changes in the Steering Group. The current members are: Charles Manski, Department of Economics, Northwestern University, Evanston, USA; Mark Sculpher, Centre for Health Economics, University of York; Anne Spencer, College of Health and Medicine, University of Exeter Medical School, University of Exeter.…

Full Study Team Appointed

June 9, 2020 The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s Steering Group and come from across the United Kingdom, thereby helping to…

Full steering group appointed

April 1, 2020 Several expressions of interest were received for joining the Steering Group of the new UK EQ-5D-5L valuation study. At their meeting of 11MAR2020 the initial members of the Steering Group decided to appoint three academic experts to join the Steering Group: Charles Manski, Department of Economics, Northwestern…

Call for expression of interest

February 12, 2020 On 24 October 2019 EuroQol and NICE announced that a new EQ-5D-5L valuation study will be undertaken in the UK, following NICE’s decision not to use the EQ-5D-5L value set for England (Devlin et al 2018). This new study will be funded and managed by EuroQol. NICE,…

Back To Top
Search